When a patient is diagnosed with advanced and untreatable kidney cancer, it can be a devastating blow. However, the story of one patient's journey shows how technology and innovation can sometimes provide a glimmer of hope. Here, we delve into the remarkable case of a patient who underwent robot-assisted surgery for his previously untreatable kidney cancer, and the incredible success that followed. Despite the odds being stacked against him, this patient's experience highlights the transformative potential of robotic technology in the field of cancer treatment.
Bilateral kidney cancer: A challenge
Bilateral kidney cancer, also known as bilateral renal cell carcinoma, refers to the presence of cancerous tumors in both kidneys. These tumors can be present in both kidneys simultaneously or at different times and can be either synchronous, where tumors are present in both kidneys at the same time, or metachronous, where tumors develop in the second kidney after the first kidney tumor has been treated.
The prevalence of bilateral kidney cancer is relatively low, accounting for approximately 1-5 percent of all renal cell carcinomas (RCCs), which are the most common type of kidney cancer. But most importantly, bilateral kidney cancer (BCC) can present a significant challenge for treatment, as both kidneys may need to be removed or treated with different modalities to ensure the best outcome for the patient.
Advantages of robot-assisted surgery
A study that analyzed efficacy of robot-assisted surgery to treat multiple bilateral kidney tumors, found the procedure was successful in all cases, with no major complications or loss of kidney function.
هذه القصة مأخوذة من طبعة July 2023 من Healthcare Radius.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة July 2023 من Healthcare Radius.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Dengue-related searches surge on Justdial
Justdial data reveals significant increase in dengue-related searches and pest control services this monsoon season, amid severe dengue outbreak in India.
Ipca launches NovaLead's Diulcus for diabetic foot ulcer
Ipca Laboratories launches NovaLead's patented drug Diulcus, for the treatment of diabetic foot ulcer in India.
Sahyadri Hospitals unveils advanced radiotherapy treatment
Sahyadri Hospitals launches Asia's first advanced radiotherapy treatment, Radixact X9 system with Vital Hold technology for precise cancer treatment.
Complex liver transplant saves diabetic patient
Wockhardt Hospitals, Mumbai Central and South Asian Liver Institute provide liver transplant services to a Botswanian patient.
Gynecological cancers rise in young Indian women
Experts stress need for awareness, early screening, and advanced treatment options like robotic-assisted surgery for gynecological cancers.
Mahajan Imaging, Siemens unveil AI diagnostic analyzer
Mahajan Imaging and Labs and Siemens Healthineers launch India's first Al-diagnostic analyzer.
Nimotuzumab boosts head and neck cancer survival - Tata Memorial study
A Tata Memorial study finds Nimotuzumab increases 10-year survival rate for head and neck cancer patients.
Kolkata doctor rape and murder: Everything you wanted to know
Protesting doctors demand better workplace safety and stricter policy measures.
AYUSH treatments to be covered under PM-JAY?
Very soon, AYUSH treatments may be covered under AB PM-JAY.
WHAT DOCTORS MUST TELL PATIENTS ABOUT DRY EYE SYNDROME
Dry eye syndrome affects lakhs of people globally, causing discomfort and vision issues. Learn how doctors must guide patients about managing it.